Differential β-cell response to glucose, glucagon, and arginine during progression to type I (insulin-dependent) diabetes mellitus
- 1 March 1996
- journal article
- Published by Elsevier in Metabolism
- Vol. 45 (3) , 306-314
- https://doi.org/10.1016/s0026-0495(96)90283-8
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Combined Analysis of Islet Cell Antibodies That Cross-React with Mouse Pancreas, Antibodies to the Mr 64,000 Islet Protein, and Antibodies to Glutamate Decarboxylase in Type I Diabetic PatientsDiabetes Care, 1994
- Acute Insulin Response to Glucose and Glucagon in Subjects at Risk of Developing Type I DiabetesDiabetes Care, 1993
- Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetesDiabetes, 1992
- Endocrine-metabolic function in remission-phase IDDM during administration of cyclosporineDiabetes, 1991
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylaseNature, 1990
- Type-I Diabetes: A Chronic Autoimmune Disease of Human, Mouse, and RatAnnual Review of Immunology, 1990
- Inhibition of Glucose Transport into Rat Islet Cells by Immunoglobulins from Patients with New-Onset Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1990
- Analysis of Metabolic Progression to Type I Diabetes in ICA+ Relatives of Patients With Type I DiabetesDiabetes Care, 1990
- PREDICTING INSULIN-DEPENDENT DIABETESThe Lancet, 1988
- Reproducibility of βCell Function Estimates in Non-Insulin-Dependent Diabetes MellitusDiabetes Care, 1987